{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "COVID-19",
      "SARS-CoV-2",
      "antiviral therapy",
      "vaccine",
      "virus-host interactions"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "34490732",
  "DateCompleted": {
    "Year": "2021",
    "Month": "09",
    "Day": "21"
  },
  "DateRevised": {
    "Year": "2021",
    "Month": "12",
    "Day": "07"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1111/febs.16167"
    ],
    "Journal": {
      "ISSN": "1742-4658",
      "JournalIssue": {
        "Volume": "288",
        "Issue": "17",
        "PubDate": {
          "Year": "2021",
          "Month": "Sep"
        }
      },
      "Title": "The FEBS journal",
      "ISOAbbreviation": "FEBS J"
    },
    "ArticleTitle": "Spotlight on COVID-19: eighteen months on.",
    "Pagination": {
      "StartPage": "4992",
      "EndPage": "4995",
      "MedlinePgn": "4992-4995"
    },
    "Abstract": {
      "AbstractText": [
        "In this Editorial, we highlight the contents of The FEBS Journal's second Special Issue focussed on COVID-19. The issue covers a variety of aspects related to COVID-19, ranging from the most recent improvements in therapies and the significant impact of rapidly developed COVID-19 vaccines to the emergence of variants of SARS-CoV-2, the role of the immune system in the various stages of the disease and the impact of the disease in different organs. We hope that this collection of articles will give readers an informative and critical perspective on recent advances in understanding and treating COVID-19."
      ],
      "CopyrightInformation": "\u00a9 2021 Federation of European Biochemical Societies."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Laboratory of Cardiovascular Biology, The International Centre for Genetic Engineering and Biotechnology, Trieste, Italy."
          }
        ],
        "LastName": "Zacchigna",
        "ForeName": "Serena",
        "Initials": "S"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Laboratory of Molecular Virology, The International Centre for Genetic Engineering and Biotechnology, Trieste, Italy."
          }
        ],
        "LastName": "Marcello",
        "ForeName": "Alessandro",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Laboratory of Tumour Virology, The International Centre for Genetic Engineering and Biotechnology, Trieste, Italy."
          }
        ],
        "LastName": "Banks",
        "ForeName": "Lawrence",
        "Initials": "L"
      }
    ],
    "PublicationTypeList": [
      "Editorial"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "FEBS J",
    "NlmUniqueID": "101229646",
    "ISSNLinking": "1742-464X"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "COVID-19 Vaccines"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "epidemiology",
        "therapy",
        "virology"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "COVID-19 Vaccines"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Disease Management"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "immunology"
      ],
      "DescriptorName": "Immune System"
    },
    {
      "QualifierName": [
        "genetics",
        "pathogenicity"
      ],
      "DescriptorName": "SARS-CoV-2"
    }
  ]
}